2 or 3 yrs from now 5 to 10 BILLION DOLLAR CAP period. HERE'S WHY
A vaccine for HIV? Are you kidding me? Do you know the monetary value fo that?
Do that math.
Add up the World's infected population and then multiply by 500-1000 dollars per shot...and that is on the cheap.
Then multiply it again by the case by case new incident...
WE ARE TALKING 10's of billions a year in profit. IMO.
Once Phase II comes out they can conduct a fast track through the EU and use the data for a comparable RA submission in the US. The clinical requirements and costs and timeline for any NDA are severely reduced by going this rout. I ought to know, I am working on two right now for my own company. 3 yrs we achieve what would take 6 in the US. So, with that said, the study opens the doors wide for a potential partnership as big molecule tries to get in on the gold rush. Don't be surprised of buyout talk offers. Look at Onyx. I think Inovio will partner and not be bought out though...I think too many investors have long term growth agendas in mind and no flippage. Seems like it from the corp. history. IMO